Page last updated: 2024-09-05

paromomycin and Opportunistic Infections

paromomycin has been researched along with Opportunistic Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barragán, P; López-Velez, R; Olmo, M; Podzamczer, D1
Allerberger, F; Feichtinger, H; Kropshofer, G; Nachbaur, D; Niederwieser, D1

Other Studies

2 other study(ies) available for paromomycin and Opportunistic Infections

ArticleYear
Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.
    The American journal of tropical medicine and hygiene, 2010, Volume: 83, Issue:1

    Topics: AIDS-Related Opportunistic Infections; HIV; HIV Infections; HIV-1; Humans; Itraconazole; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Opportunistic Infections; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Recurrence; Treatment Failure

2010
Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2.
    Bone marrow transplantation, 1997, Volume: 19, Issue:12

    Topics: Adult; Antigens, CD34; Azithromycin; Cryptosporidiosis; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Immunosuppression Therapy; Interleukin-2; Lung Diseases, Parasitic; Lymphocyte Subsets; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Opportunistic Infections; Paromomycin; Recombinant Proteins; Transplantation, Autologous

1997